As of 2025-07-07, the Intrinsic Value of Melexis NV (MELE.BR) is 40.08 EUR. This MELE.BR valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 72.30 EUR, the upside of Melexis NV is -44.60%.
The range of the Intrinsic Value is 29.03 - 65.08 EUR
Based on its market price of 72.30 EUR and our intrinsic valuation, Melexis NV (MELE.BR) is overvalued by 44.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 29.03 - 65.08 | 40.08 | -44.6% |
| DCF (Growth 10y) | 36.70 - 80.78 | 50.34 | -30.4% |
| DCF (EBITDA 5y) | 33.36 - 62.01 | 44.07 | -39.0% |
| DCF (EBITDA 10y) | 39.26 - 75.27 | 52.46 | -27.4% |
| Fair Value | 88.55 - 88.55 | 88.55 | 22.48% |
| P/E | 59.84 - 74.81 | 67.61 | -6.5% |
| EV/EBITDA | 28.66 - 74.20 | 52.22 | -27.8% |
| EPV | 33.80 - 56.45 | 45.12 | -37.6% |
| DDM - Stable | 21.69 - 53.99 | 37.84 | -47.7% |
| DDM - Multi | 25.99 - 52.17 | 34.89 | -51.7% |
| Market Cap (mil) | 2,920.92 |
| Beta | 1.60 |
| Outstanding shares (mil) | 40.40 |
| Enterprise Value (mil) | 3,110.42 |
| Market risk premium | 5.98% |
| Cost of Equity | 10.67% |
| Cost of Debt | 18.74% |
| WACC | 11.02% |